Company intelligence / Profile preview

Shanghai Liuhetang Biotechnology Xiangcheng Pharmaceutical

Xiangcheng, Henan, China

Ownership: Private
Development stage: Other

Overview

Shanghai Liuhetang Biotechnology Xiangcheng Pharmaceutical is a comprehensive modern pharmaceutical company with a long history in the manufacture of both chemical and traditional Chinese medicines. The company operates 16 production lines and holds 51 drug approval numbers for products including small-volume injections, oral liquids, and capsules. It is primarily focused on the commercialization of anti-infective, cardiovascular, and respiratory treatments.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Small moleculeBiologicPeptides
Industry: Biotech

Partnerships

Unnamed Shanghai Research Institute

Beyond the preview

Go deeper on Shanghai Liuhetang Biotechnology Xiangcheng Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Liuhetang Biotechnology Xiangcheng Pharmaceutical.

Explore the full profile